共 80 条
- [1] Briot K(2014)2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis Jt Bone Spine 81 493-501
- [2] Cortet B(2002)Effects of dexamethasone on lymphocyte proliferation and cytokine production in rheumatoid arthritis J Rheumatol 29 46-51
- [3] Roux C(2011)Ginsenoside Rg1, a novel glucocorticoid receptor agonist of plant origin, maintains glucocorticoid efficacy with reduced side effects J Immunol 187 942-950
- [4] Fardet L(2009)Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL Arthritis Rheum 60 1427-1437
- [5] Abitbol V(2018)Elevated expression of Dkk-1 by glucocorticoid treatment impairs bone regenerative capacity of adipose tissue-derived mesenchymal stem cells Stem Cells Dev 27 85-99
- [6] Bacchetta J(2014)Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis Rheumatology (Oxford) 53 1742-1751
- [7] De A(2016)Glucocorticoid Signaling and Bone Biology Horm Metab Res 48 755-763
- [8] Blotta HM(2017)Suppression of human arthritis synovial fibroblasts inflammation using dexamethasone-carbon nanotubes via increasing caveolin-dependent endocytosis and recovering mitochondrial membrane potential Int J Nanomedicine 12 5761-5779
- [9] Mamoni RL(2014)Are glucocorticoids harmful to bone in early rheumatoid arthritis? Ann N Y Acad Sci 1318 50-54
- [10] Louzada P(2007)Effects of glucocorticoids on inflammation and arthritis Curr Opin Rheumatol 19 302-307